Previous studies showed that PXT-treated epithelial osteosarcoma (U-2 OS) and non-small cell lung cancer (NSCLC) cells accumulate in the G2/M phase and thereafter undergo apoptosis via caspase-3 activation [27,28,29]. This evidence concerns the gene CASP3 and non-small cell lung carcinoma.